{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:59:02Z","timestamp":1782741542637,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Viridian Therapeutics, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40123-026-01393-2","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:38:07Z","timestamp":1781077087000},"page":"2395-2412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impacts of Thyroid Eye Disease (TED), Beyond the Signs and Symptoms: Results from the ElevaTED Patient Survey"],"prefix":"10.1007","volume":"15","author":[{"given":"Jody G.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry R.","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Helfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shula","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly P.","family":"Cockerham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, natural history, risk factors, and prevention of Graves\u2019 orbitopathy. Front Endocrinol (Lausanne). 2020;11:615993.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"1283374","DOI":"10.3389\/fendo.2023.1283374","volume":"14","author":"TJ Smith","year":"2023","unstructured":"Smith TJ, Heged\u00fcs L, Lesser I, et al. How patients experience thyroid eye disease. Front Endocrinol (Lausanne). 2023;14:1283374.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"1565762","DOI":"10.3389\/fopht.2025.1565762","volume":"5","author":"MA Tamhankar","year":"2025","unstructured":"Tamhankar MA, Raza S, Brutsaert E, et al. The burden of illness in thyroid eye disease: current state of the evidence. Front Ophthalmol (Lausanne). 2025;5:1565762.","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1089\/thy.2024.0304","volume":"34","author":"KN Rachmasari","year":"2024","unstructured":"Rachmasari KN, Hamadi D, Thapa P, Bradley EA, Stan MN. The epidemiology of thyroid eye disease in Olmsted County, Minnesota, 2005\u20132020. Thyroid. 2024;34:1522\u201330.","journal-title":"Thyroid"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1089\/thy.2022.0251","volume":"32","author":"HB Burch","year":"2022","unstructured":"Burch HB, Perros P, Bednarczuk T, et al. Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association. Thyroid. 2022;32:1439\u201370.","journal-title":"Thyroid"},{"key":"1393_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s40123-021-00385-8","volume":"10","author":"KP Cockerham","year":"2021","unstructured":"Cockerham KP, Padnick-Silver L, Stuertz N, Francis-Sedlak M, Holt RJ. Quality of life in patients with chronic thyroid eye disease in the United States. Ophthalmol Ther. 2021;10:975\u201387.","journal-title":"Ophthalmol Ther"},{"issue":"185","key":"1393_CR7","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"2021","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, et al. European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol. 2021;2021(185):G43-67.","journal-title":"Eur J Endocrinol"},{"key":"1393_CR8","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0189","volume":"11","author":"HB Burch","year":"2022","unstructured":"Burch HB, Perros P, Bednarczuk T, et al. Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association. Eur Thyroid J. 2022;11:e220189.","journal-title":"Eur Thyroid J"},{"key":"1393_CR9","unstructured":"US Food & Drug Administration. Focus area: patient-reported outcomes and other clinical outcome assessments. https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-area-patient-reported-outcomes-and-other-clinical-outcome-assessments. Jan 20, 2025. Accessed Sept 29, 2025."},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/IOP.0000000000001446","volume":"36","author":"THB Lee","year":"2020","unstructured":"Lee THB, Sundar G. Quality of life in thyroid eye disease: a systematic review. Ophthalmic Plast Reconstr Surg. 2020;36:118\u201326.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/bjophthalmol-2011-300487","volume":"95","author":"T Fayers","year":"2011","unstructured":"Fayers T, Dolman PJ. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease. Br J Ophthalmol. 2011;95:1670\u20134.","journal-title":"Br J Ophthalmol"},{"key":"1393_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01241.x","volume":"54","author":"CB Terwee","year":"2001","unstructured":"Terwee CB, Dekker FW, Mourits MP, et al. Interpretation and validity of changes in scores on the Graves\u2019 ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf). 2001;54:391\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1393_CR13","first-page":"368","volume":"103","author":"RP Yeatts","year":"2005","unstructured":"Yeatts RP. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc. 2005;103:368\u2013411.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.7.5.14","volume":"7","author":"MHY Wong","year":"2018","unstructured":"Wong MHY, Fenwick E, Aw AT, et al. Development and validation of the Singapore thyroid eye disease quality of life questionnaire. Transl Vis Sci Technol. 2018;7:14.","journal-title":"Transl Vis Sci Technol"},{"key":"1393_CR15","volume":"14","author":"H Zhang","year":"2025","unstructured":"Zhang H, Wu S, Yang L, et al. Investigating factors influencing quality of life in thyroid eye disease: insight from machine learning approaches. Eur Thyroid J. 2025;14:e240292.","journal-title":"Eur Thyroid J"},{"key":"1393_CR16","first-page":"112067212614225","volume":"11","author":"AC Lai","year":"2026","unstructured":"Lai AC, Yu BE, Malvankar-Mehta M. The burden of thyroid eye disease: evaluating treatment outcomes on quality of life. Eur J Ophthalmol. 2026;11:11206721261422570.","journal-title":"Eur J Ophthalmol"},{"key":"1393_CR17","doi-asserted-by":"publisher","first-page":"1565762","DOI":"10.3389\/fopht.2025.1565762","volume":"5","author":"MA Tamhankar","year":"2025","unstructured":"Tamhankar MA, Raza S, Brutsaert E, et al. The burden of illness in thyroid eye disease: current state of the evidence. Front Ophthalmol (Lausanne). 2025;5:1565762.","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"Suppl_1","key":"1393_CR18","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1210\/clinem\/dgac328","volume":"107","author":"TJ Smith","year":"2022","unstructured":"Smith TJ. Understanding pathogenesis intersects with effective treatment for thyroid eye disease. J Clin Endocrinol Metab. 2022;107(Suppl_1):S13-26.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl_1","key":"1393_CR19","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1210\/clinem\/dgac230","volume":"107","author":"A Sharma","year":"2022","unstructured":"Sharma A, Stan MN, Rootman DB. Measuring health-related quality of life in thyroid eye disease. J Clin Endocrinol Metab. 2022;107(Suppl_1):S27-35.","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IOP.0000000000002318","volume":"39","author":"TC Lee","year":"2023","unstructured":"Lee TC, Radha-Saseendrakumar B, Delavar A, et al. Evaluation of depression and anxiety in a diverse population with thyroid eye disease using the nationwide NIH All of US database. Ophthalmic Plast Reconstr Surg. 2023;39:281\u20137.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1393_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1530\/EJE-11-0055","volume":"164","author":"S Estcourt","year":"2011","unstructured":"Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol. 2011;164:649\u201355.","journal-title":"Eur J Endocrinol"},{"key":"1393_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.82.7.773","volume":"82","author":"CB Terwee","year":"1998","unstructured":"Terwee CB, Gerding MN, Dekker FW, et al. Development of a disease specific quality of life questionnaire for patients with Graves\u2019 ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82:773\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1393_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137.","journal-title":"Arch Intern Med"},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.5664\/jcsm.7478","volume":"14","author":"E Snyder","year":"2018","unstructured":"Snyder E, Cai B, DeMuro C, Morrison MF, Ball W. A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression. J Clin Sleep Med. 2018;14:1849\u201357.","journal-title":"J Clin Sleep Med"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11136-020-02650-y","volume":"30","author":"R Jiang","year":"2021","unstructured":"Jiang R, Janssen MFB, Pickard AS. US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Qual Life Res. 2021;30:803\u201316.","journal-title":"Qual Life Res"},{"key":"1393_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0895-4356(88)90138-2","volume":"41","author":"CD Jenkins","year":"1988","unstructured":"Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41:313\u201321.","journal-title":"J Clin Epidemiol"},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353\u201365.","journal-title":"Pharmacoeconomics"},{"key":"1393_CR29","first-page":"JE06","volume":"11","author":"C Arora","year":"2017","unstructured":"Arora C, Sinha B, Malhotra A, Ranjan P. Development and validation of health education tools and evaluation questionnaires for improving patient care in lifestyle related diseases. J Clin Diagn Res. 2017;11:JE06-9.","journal-title":"J Clin Diagn Res"},{"key":"1393_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.sleep.2021.05.022","volume":"84","author":"S Lee","year":"2021","unstructured":"Lee S, Kim JH, Chung JH. The association between sleep quality and quality of life: a population-based study. Sleep Med. 2021;84:121\u20136.","journal-title":"Sleep Med"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s40001-025-02691-4","volume":"30","author":"H Chen","year":"2025","unstructured":"Chen H, Cao J, Yin J, et al. Sleep quality and its determinants in patients with thyroid eye disease: a cross-sectional study. Eur J Med Res. 2025;30:446.","journal-title":"Eur J Med Res"},{"key":"1393_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.eprac.2022.06.003","volume":"28","author":"Y Wang","year":"2022","unstructured":"Wang Y, Padnick-Silver L, Francis-Sedlak M, Holt RJ, Foley C, Douglas RS. Inflammatory and noninflammatory thyroid eye disease: comparison of disease signs, symptoms, and quality of life in patients in the United States. Endocr Pract. 2022;28:842\u20136.","journal-title":"Endocr Pract"},{"key":"1393_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40123-020-00318-x","volume":"10","author":"Y Wang","year":"2021","unstructured":"Wang Y, Sharma A, Padnick-Silver L, et al. Physician-perceived impact of thyroid eye disease on patient quality of life in the United States. Ophthalmol Ther. 2021;10:75\u201387.","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"1393_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362(8):726\u201338.","journal-title":"N Engl J Med"},{"issue":"16","key":"1393_CR35","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves\u2019 disease. N Engl J Med. 2016;375(16):1552\u201365.","journal-title":"N Engl J Med"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01393-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01393-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01393-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:25:52Z","timestamp":1782739552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01393-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01393-2","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jody G. Abrams and Kimberly P. Cockerham are clinical study investigators and consultants for Viridian Therapeutics, Inc. Christine Gustafson is Executive Director at the TED Community Organization, which has received financial sponsorships from Viridian Therapeutics, Inc. Jennifer Helfer and Shula Pollard are employees of Viridian Therapeutics, Inc. Sherry R. Danese and Julie A. Ulloa are employees of Outcomes Insights and were contracted and received financial compensation from Viridian Therapeutics Inc. to conduct this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"ElevaTED survey materials, in English and Spanish, were reviewed, and a waiver was granted by Advarra, an independent review board prior to study initiation, on May\u00a013, 2024, under 45 CFR \u00a7 46.104(d). Participation in the survey was voluntary, and all participants provided informed consent for their data to be used anonymously or in aggregate prior to entering the survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}